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Aim. To investigate the effects of the rhLIF recombinant human leukemia inhibitory factor on the 
structural and functional changes in the central nervous system in the cuprizone-induced experi-
mental model of multiple sclerosis in mice and to evaluate the involvement of the brain mac-
rophages, T-lymphocytes and antioxidant enzymes in the observed rhLIF effects. Methods. Young 
129/Sv mice were fed with the cuprizone neurotoxin daily for three weeks. rhLIF was injected 
daily (50 μg/kg) after seven days of the cuprizone treatment. We used histology, flow cytometry, 
spectrophotometric and functional methods. Results. The cuprizone treatment resulted in an in-
crease in the number of the brain and spinal cord neurons with destructive changes, the brain 
macrophages, CD3+-cells and the content of malondialdehyde; it changes the behavior of animals, 
decreases the brain superoxide dismutase and glutathione peroxidase activities. The rhLIF injection 
partially or completely restored the cuprizone-changed  parameters. The effect of rhLIF was 
preserved during two months after the experiment completion. Conclusions. The neuroprotective 
effect of rhLIF is connected with a decrease in the cuprizone-induced changes in the number of 
the brain T-cells and macrophages and the activity of antioxidant enzymes.
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Introduction
Multiple sclerosis is one of the most widespread 
demyelinating pathologies of the central nervous 
system (CNS) with the damages of both neuron 
pericarion and myelin of nerve fiber accompa-
nied by the development of motor, emotional, 
vegetative and cognitive impairments [1, 2]. 
Recently, new approaches to the treatment of 
multiple sclerosis have been developed. One of 
such promising approaches is the activation of 
own neural stem cells (NSCs)/progenitors in 
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CNS [3]. Activation of own NSCs can be influ-
enced by various cellular factors, in particular, 
cytokines. The leukemia inhibitory factor (LIF) 
is a polyfunctional cytokine of the interleukin 6 
(IL6) family playing an important role in the 
nervous system development and its post-injury 
reco very [4–10]. 
In neurodegenerative diseases, including mul-
tiple sclerosis, the important links in the mech-
anism of nerve cell damage are the activation of 
microglia/macrophages and T-lymphocytes, as 
well as the oxidative stress accompanying neu-
roinflammation [11, 12]. It has been established 
that during first hours/days after damage of the 
nervous system, LIF participates in the initiation 
of a neuroinflammatory reaction, in particular, 
attracting macrophages into the inflammatory 
area [13]. In this case, the expression of mRNA 
LIF in the glial cells of the nervous system in-
creases [14]. LIF reveals also anti-inflammatory 
effects [15].
Studies on the possible ways of neuropro-
tective influence of recombinant human LIF 
(rhLIF) require adequate experimental models 
of demyelinating CNS pathologies. As such, 
the toxic model of multiple sclerosis, induced 
by cuprizone, is widely used. We as well as 
other investigators observed a damage of the 
oligodendrocytes and neurons, neuroinflam-
mation, oxidative stress and a reduced activity 
of the antioxidant enzymes in CNS of animals 
with the experimental cuprizone-induced mul-
tiple sclerosis [11, 14, 16–18].
The aim of our work was to investigate the 
effects of rhLIF on the structural and func-
tional changes in CNS in the cuprizone-in-
duced experimental model of multiple sclero-
sis in mice and to evaluate the involvement of 
the brain macrophages, T-lymphocytes and 
antioxidant enzymes in the realization of LIF 
effects.
Materials and Methods
Animals 
Experiments were conducted on young 
(3-5 months) female 129/Sv “wild type” (H-2b) 
mice (n=42) from vivarium of the Institute of 
Genetic and Regenerative Medicine NAMS of 
Ukraine (IGRM). Mice were kept in standard 
vivarium conditions with a fixed light regimen 
12:12. Biological tissues for studies were ta ken 
from animals at 9:00 a.m. by ether anesthesia. 
All experiments were carried out according to 
“European Convention for the Protection of 
Vertebrate Animals used for experimental and 
other scientific purposes” (Strasburg, 1986) 
(from 21.02.2006).
Cuprizone-induced demyelination. Mice were 
given cuprizone [bis(cyclohexylidene hydra zide)] 
(«Sigma», USA), in an amount of 0.2 % by 
weight, mixed with food, daily for 3 weeks [17].
Recombinant human LIF (rhLIF). LIF was 
cloned with RT-PCR technology using human 
placenta RNA as a template and was expressed 
in E.coli. The biological activity was checked 
on the mouse myeloid leukemia cell line M1 [19]. 
Cytokine was injected intraperitonealy daily, 
50 μg/kg of body weight [20], after 7 days of 
receiving cuprizone (14 injections) [21]. The 
control group of mice fed with cuprizone re-
ceived injections of phosphate buf fered saline 
(PBS) according to a similar scheme.
Experimental groups: 1 — mice were kept 
on standard diet without cuprizone (untreated 
mice); 2 — mice receiving cuprizone-contain-
ing food for 3 weeks and PBS injections (con-
trol group); 3 — mice receiving both cupri-
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zone-containg food and rhLIF injections. Each 
group included 14 mice. Experiments were 
conducted after completion of cuprizone treat-
ment on 7, 21 and 60 days. 
For morphological studies of the CNS 
structures (cortex, cerebellum and lumbar spi-
nal cord) the histological sections were stained 
with toluidine blue (by Nissl) [17, 22]. The 
number of unchanged neurons and neurons 
with moderate and severe structural changes 
were determined by morphometric analysis. 
Behavioral responses of mice were studied 
using «open field» test [22, 23]. The number 
of squares crossed (horizontal locomotor acti-
vity) and faecal boluses (emotional activity) 
and looks into minks (search activity) were 
recorded for 3 min. 
Malondialdehyde (MDA) content in brain 
tissues was determined according to Uchi-
yama [24].
Activities of antioxidant enzymes were as-
sessed in supernatants of the brain homoge-
nates (cerebellum, forebrain) using μQuant 
Bio-Tek spectrophotometer (USA) [25]. 
Functional activity of brain macrophages. 
The brain microglial cells/macrophages and 
blood-derived macrophages have similar pa-
rameters, for example, the possibility to phago-
cytosis of latex beads [26–28]. Brain suspen-
sion of adherent cells was cultivated with latex 
beads for 45 min at 37о C in 5 % CO2. Then 
these cells were fixed and stained with 
Romanovsky-Gimsa. The percentage of brain 
macrophages capable of phagocytosis of latex 
beads (phagocytic index) and the amount of 
latex beads, which were phagocytosed by one 
macrophage (phagocytic number) were count-
ed under light microscope. All reagents were 
supplied from Sigma (USA). 
Flow cytometric analysis of CD3+ and 
CD11b+-cells. The cells suspension of the brain 
tissue was incubated with monoclonal antibodies 
for 20 min at 4˚ C in combination with the satu-
rating amounts of phycoerythrin (PE)-conjugated 
antibodies against CD3 (dilution 1:50) and fluo-
rescein isothiocyanate (FITC)-conjugated anti-
bodies against CD11b (dilution 1:50), as recom-
mended by the manufacturer (Becton Dickinson, 
USA). Measurements were performed on the flow 
cytometer BD FACSAria (Becton Dickinson, 
USA), and the data analysis was performed using 
the BD FACS Diva 6.1 software. 
Statistical analysis of the results was carried 
out using the Student’s t-criterion [29]. The 
differences between the means of comparable 
groups (M±SEM) were significant at p < 0.05. 
Results
Changes in the structure of neurons and 
brain macrophages activity in mice during 
early period of cuprizone treatment. One of 
the early manifestations of the development of 
cuprizone-induced multiple sclerosis is a 
change in the oligodendrocyte functioning and 
apoptosis development [14]. However, the 
neuronal structural changes in such animals 
are poorly studied. Histological analysis of 
brain structures has shown that a proportion 
of neurons with moderate structural changes 
increased in the cortex and cerebellum of mice 
after 7 days of the cuprizone treatment 
(Fig. 1, A, B). These results are in agreement 
with our earlier data: the horizontal locomotor 
activity revealed a significant decrease 
(1.8-fold, p < 0.05) in the young 129/Sv mice 
after 7 days of the cuprizone treatment com-
paring to the untreated mice [21]. Apart from 
the changes in brain neurons of the cuprizone-
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treated mice, the number and the activity of 
brain macrophages increased if compared to 
the similar parameters in the group without 
cuprizone treatment (Fig. 2, A, B).
Influence of rhLIF injections on struc-
tural and functional changes in the CNS of 
mice treated with cuprizone during three 
weeks. After 7 days of the cuprizone treatment, 
rhLIF in the concentration of 50 μg/kg of body 
weight was injected. The control group of 
animals continued to receive only cuprizone. 
Comparison of the results of morphometric 
analysis of CNS structures of above groups 
showed a lower proportion of unchanged neu-
rons and a greater share of the neurons with 
destructive changes in the control group, 
whereas in the experimental group the direc-
tions of these changes were opposite (Fig. 3, A, 
B, C). Thus, the rhLIF injections to cuprizone-
treated mice resulted in the restorative and 
compensatory neuronal responses to a damage.
The behavioral reactions were significantly 
worsened in the cuprizone-treated mice (see 
Fig. 4, A, B, C). Injections of rhLIF led to an 
increase of the locomotor and search activity 
in comparison with similar parameters in the 
control group, although they remained lower 
than in untreated mice (Fig. 4, A, C). After 
injection of cytokine we observed an increase 
in the emotional activity to the level observed 
in the untreated group (Fig. 4, B).
Influence of rhLIF injections on brain 
macrophages, T cells and antioxidant en-
zymes activity in mice treated with cuprizone 
during three weeks. The number of active 
macrophages in the brain of mice after 3 weeks 
A
 
B
Fig. 1. Structural changes of brain neurons (A — cortex, B — cerebellum) in mice after 7 days of cuprizone treatment. 
A
 
B
Fig. 2. Macrophages activity (A — phagocytic index, B — phagocytic number) in mice after 7 days of cuprizone treat-
ment. p < 0.05 vs untreated mice.
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of the cuprizone treatment was higher than in 
the untreated animals and the rhLIF injections 
in such mice did not affect this parameter 
(Fig. 5, A, B). The number of CD11b+ (Mac1+) 
cells in the brain of cuprizone-treated mice 
(2.8 ± 0.2 %) did not change in comparison 
with the untreated group (2.8 ± 0.1 %), but 
after cytokine injections this number decreased 
to 1.8 ± 0.2 % (p < 0.05).
The number of CD3+ cells in the brain of 
mice significantly increased after the cuprizone 
treatment (Fig. 5, C). However, the number of 
CD3+ cells decreased following the rhLIF in-
jections, remaining still higher than in the 
untreated mice (Fig. 5, C).
Under the cuprizone influence one of the 
indices of oxidative stress (MDA content) 
significantly increased in the forebrain 
whereas the administration of rhLIF reduced 
the MDA content to the level of untreated 
A
B
 
C
Fig. 4. The influence of cuprizone and rhLIF on the be-
havioural reactions (A — horizontal locomotor activity, 
B — emotional activity, C — search activity) in mice. 
p < 0.05: * — vs untreated mice; # — vs cuprizone. Cu-
prizone treatment lasted 3 weeks.
A
 
B
C
 
Fig. 3. The influence of cuprizone and rhLIF on the struc-
tural changes of CNS neurons (A — cortex, B — cerebel-
lum, C — lumbar spinal cord) in mice.
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mice (Table). The superoxide dismutase 
(SOD) activity was significantly reduced in 
the forebrain of mice receiving cuprizone 
whereas the rhLIF injections restored this 
activity to the level of untreated animals 
(Table).
The activation of glutathione peroxidase 
(GPx) was observed in the forebrain of the 
mice receiving both cuprizone and cytokine 
(Table). After the cuprizone treatment the 
GPx activity in the cerebellum was signifi-
cantly reduced whereas the rhLIF injections 
Table. Malondialdehyde content and the activity of antioxidant enzymes in the brain structures of mice 
receiving cuprizone and rhLIF, M ± m
Indice
Experimental group of mice
Untreated Cuprizone Cuprizone +rhLIF
Forebrain
Malondialdehyde (nmol/mg) 1.50±0.10 2.10±0.20* 1.60±0.10#
Superoxide dismutase (U/mg·min) 12.75±0.35 11.50±0.28* 12.0±0.53
Catalase (µmol/mg·min) 1.28±0.12 1.25±0.09 1.59±0.26
Glutathione peroxidase (nmol/mg·min) 5.23±0.21 5.72±0.94 6.56±0.32*
Cerebellum
Malondialdehyde (nmol/mg) 1.40±0.10 1.60±0.10& 1.70±0.20
Superoxide dismutase (U/mg·min) 12.90±0.35 12.75±0.14& 13.50±0.35&
Catalase (µmol/mg·min) 1.44±0.05 1.29±0.07 1.40±0.17
Glutathione peroxidase (nmol/mg·min) 8.83±0.50& 7.50±0.11* 8.53±0.19#
Note: p < 0.05: * — vs untreated mice; # — vs cuprizone (3-week treatment); & — vs forebrain. Data of antioxidant enzyme 
activity in the cerebellum were shown earlier [30].
A
 
B
C
 
Fig. 5. The parameters of the macrophages activity (A — 
phagocytic index, B — phagocytic number) and the num-
ber of CD3+ cells (C) in the brain of cuprizone — and 
rhLIF — treated mice. p<0.05: * — vs untreated mice; 
# — vs cuprizone. Cuprizone treatment lasted 3 weeks. 
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restored it to the level of untreated animals 
(Table). 
Thus, the cuprizone-induced brain damage 
led to an increase in the number of macro-
phages and T-lymphocytes and inhibited the 
activity of antioxidant enzymes (SOD, GPx) 
in the mouse brain structures. This neurotoxin 
effect was significantly lower in the case of 
co-administration of cuprizone and rhLIF.
The long-term effects of rhLIF injections 
on cuprizone-induced changes in the neuronal 
structure and T-lymphocyte number in the 
mouse brain. Histological analysis of the mouse 
brain structures two months after completion of 
the cuprizone treatment showed that the number 
of unchanged neurons, neurons with moderate 
changes and neurons with pronounced struc-
tural changes was respectively: 13 %, 69 % and 
28 % in the cortex; and 35 %, 43 % and 22 % 
in the cerebellum. The number of neurons with 
pronounced structural chan ges was lower and 
the number of unchanged neurons was higher 
in the cerebral cortex and cerebellum compared 
to the animals after 3 weeks of the neurotoxin 
treatment (Fig. 2, A, B). This fact can be ex-
plained by the reduction of neuroinflammation, 
which leads to an increase in the number of 
oligodendrocytes and remyelination [14]. In our 
study, two months after completion of adminis-
tration of rhLIF and cuprizone the number of 
neurons without changes, with moderate and 
pronounced structural changes was 26 %, 62 %, 
12 % in cerebral cortex; and 65 %, 27 %, 8 % 
in the cerebellum, respectively. Importantly, the 
number of neurons of different types in the cer-
ebellum two months after completion of the 
cuprizone treatment was comparable with their 
number after 3 weeks of the combined treatment 
with neurotoxin and rhLIF. Thus, the results 
indicate a more effective restoration of the neu-
ronal structure following the cytokine injections.
Two months after completion of the cupri-
zone treatment the horizontal locomotor acti-
vi ty (the number of crossed squares) was 
lower in the cuprizone-treated mice comparing 
to the mice receiving both cuprizone and 
rhLI F: 11.0 ± 1.5 and 25.0 ± 2.3, (p < 0.05), 
respectively. In both experimental groups, the 
indices remained lower (p < 0.05) compared 
to the untreated group (Fig 4, A).
Two months after completion of the cupri-
zone treatment the number of the brain CD3+-
cells (1.2 ± 0.1 %) was lower than just after 
completion of the 3-week neurotoxin treatment 
(p < 0.05), whereas this parameter was still 
higher than in the untreated mice (p < 0.05) 
(Fig. 5, C). However, two months after comple-
tion of the combined administration of cupri-
zone and rhLIF the number of CD3+ cells 
(1.0 ± 0.1 %) did not change noticeably compar-
ing to the untreated mice (p > 0.05) (Fig. 5, C).
So, the effects of rhLIF on the above chan-
ges induced by the cuprizone treatment re-
mained the same for a long period of time.
Discussion
The myelin-synthesizing cells (oligodendro-
cytes) underwent apoptosis in the cuprizone-
induced model of multiple sclerosis [14]. 
Using the cuprizone-induced model of multiple 
sclerosis in mice, we observed a significantly 
increased number of the neurons with destruc-
tive changes in the cortex and the cerebellum 
of the brain and in the lumbar spinal cord. 
Damage of the neuron structure is accompa-
nied with destruction of the locomotor, emo-
tional and search activities. Our results agree 
with the findings of Ganong [31]. Apparently, 
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the disorders of behavioral reactions induced 
by cuprizone result from both, the developing 
demyelination of CNS organs and the damage 
of brain and spinal cord neurons. 
In our study of the cuprizone-treated mice 
the exogenous rhLIF improved the structure 
and functioning of CNS neurons. These mor-
pho-functional changes can be explained by 
the literature data about the antiapoptotic ac-
tion of LIF and its stimulating effects on the 
proliferation of NSCs in the brain subven-
tricular zone and their differentiation into the 
neuronal direction, the formation of the oligo-
dendrocytes and myelin synthesis [8–10,14].
Today, it is supposed that the activation of 
microglia cells and T-lymphocytes is one of the 
possible mechanisms of cuprizone-induced 
damage of the neurons. In particular, it has been 
shown that microgliosis develops on the 2nd 
week of cuprizone treatment and it peaks by 
the 4-th week, being combined with the inten-
sive demyelination [11]. The activated microg-
lia cells of the brain produce an increased quan-
tity of the proinflammatory cytokines (TNF-α 
and γ-interferon) and reactive oxygen species 
(ROS), which damage both, the oligodendro-
cytes and neurons [11,32]. We observed an 
increase of the number and activity of the mac-
rophages after 7 days of the cuprizone treat-
ment and this effect remained for 3 weeks. 
The number of brain activated macrophages 
was large after the rhLIF injections. The pro-
inflammatory phenotype M1 turns into the 
anti-inflammatory phenotype M2 in the pro-
cess of the development of cuprizone-induced 
demyelination in the brain [11]. In our study 
the positive changes in the neuron structure 
allowed us to assume the realization of anti-
inflammatory effect by the macrophages fol-
lowing cytokine treatment. Additionally, the 
number of CD11b+ (Mac1+) cells in the brain 
of mice reduces after administration of rhLIF. 
As has been shown, this phenotype is specific 
not only for macrophages but also for the mi-
croglia cells [26].
Some authors consider the cuprizone-in-
duced model of multiple sclerosis as 
T-independent [12]. Kang et al. reported both 
infiltration of the brain by T-cells and their 
participation in the enhancing of the demyelin-
ation in the cuprizone-treated mice [33]. 
According to our results, we have observed an 
increase in the number of CD3+T cells in the 
brain after 3 weeks of cuprizone diet as com-
pared with the untreated mice (Fig. 5, C). 
The number of CD3+ T cells in the brain after 
the rhLIF injections decreased compared with 
the mice without cytokine (Fig. 5, C). It is known 
that in human multiple sclerosis the T-cells and 
perivascular macrophages expressing LIF are 
seen in the area of damage [34]. In the athours’ 
opinion, LIF prevents TNF-α- induced apoptosis 
of the oligodendrocytes that is an important 
mechanism for the protection of glial and neu-
ronal cells. The similar results were received on 
the model of experimental autoimmune encepha-
lomyelitis by Cao et al. [35]. Thus, the LIF, ex-
pressed by neural progenitor cells, inhibits the 
differentiation of T-helper 17 (Th 17) and produc-
tion of proinflammatory cytokine IL-17. 
According to our preliminary data, we observed 
a decrease in the number of CD4+-cells in the 
brain of cuprizone-treated mice.
After the cuprizone treatment we registered 
the reduced activity of antioxidant enzymes in 
the brain structures involved in the motor and 
emotional activity. This might be another pos-
sible mechanism of nerve cells damage caused 
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by oxidative stress factors in cuprizone-treated 
mice [16, 18]. We observed the enhancement 
of the activity of antioxidant enzymes in the 
brain along with the decrease of MDA content 
and the increase of the number of neurons 
without structural changes in the mice treated 
with both cuprizone and rhLIF. During CNS 
damage LIF inhibits the ROS generation and 
increases the SOD activity [36]. According to 
our data, LIF increases the activity of both 
SOD and GPx thereby contributing to the im-
provement of the structure of the CNS organs.
Conclusion
We observed the changes in the amount of the 
brain macrophages and T cells as well as the 
balance disturbance in the pro- and antioxidant 
factors that could contribute to the cuprizone-
induced brain neuron damage. The above 
changes were detected already at early stages 
of the neurotoxin treatment. The neuroprotec-
tive effect of rhLIF is сonnected with the de-
crease of cuprizone-induced changes in the 
number of the brain T-cells and macrophages 
and an activity of the antioxidant enzymes. 
The effect of the cytokine remained during two 
months after completion of the cuprizone ad-
ministration.The obtained results can serve as 
a basis for new approaches in cellular therapy 
for the patients with multiple sclerosis.
Acknowledgments
The study was carried out in the framework of 
“The role of the cell and endocrine factors in 
the realization of the neuroprotective proper-
ties of the stem cells in the experimental da-
ma ges of the nervous system”, being fulfilled 
by the IGRM, NAMSU (No of the state re gist-
ration 0116U000139), 2016-2018.
REFERENCES
1. Wegner C, Esiri MM, Chance SA, Palace J, Mat-
thews PM. Neocortical neuronal, synaptic, and glial loss 
in multiple sclerosis. Neurology. 2006;67(6):960–7.
2. Loma I, Heyman R. Multiple sclerosis: pathogenesis 
and treatment. Curr Neuropharmacol. 2011;9(3): 
409–16.
3. Lindvall O, Kokaia Z. Stem cells in human neuro-
degenerative disorders--time for clinical translation? 
J Clin Invest. 2010;120(1):29–40.
4. Auernhammer CJ, Melmed S. Leukemia-inhibitory 
factor-neuroimmune modulator of endocrine func-
tion. Endocr Rev. 2000;21(3):313–45.
5. Bauer S, Patterson PH. Leukemia inhibitory factor 
promotes neural stem cell self-renewal in the adult 
brain. J Neurosci. 2006;26(46):12089–99.
6. Ostasov P, Houdek Z, Cendelin J, et al. Role of 
leukemia inhibitory factor in the nervous system and 
its pathology. Rev Neurosci. 2015;26(4): 443–59.
7. Nicola NA, Babon JJ. Leukemia inhibitory factor (LIF). 
Cytokine Growth Factor Rev. 2015;26(5):533–44.
8. Buono KD, Vadlamuri D, Gan Q, Levison SW. Leu-
kemia inhibitory factor is essential for subventricu-
lar zone neural stem cell and progenitor homeosta-
sis as revealed by a novel flow cytometric analysis. 
Dev Neurosci. 2012;34(5):449–62.
9. Li Y, Zang D. The neuron regrowth is associated with 
the proliferation of neural precursor cells after leuke-
mia inhibitory factor administration following spinal 
cord injury in mice. PLoS One. 2014;9(12): e116031. 
10. Deverman BE, Patterson PH. Exogenous leukemia 
inhibitory factor stimulates oligodendrocyte pro-
genitor cell proliferation and enhances hippocampal 
remyelination. J Neurosci. 2012;32(6):2100–9.
11. Praet J, Guglielmetti C, Berneman Z, et al. Cellular 
and molecular neuropathology of the cuprizone 
mouse model: clinical relevance for multiple scle-
rosis. Neurosci Biobehav Rev. 2014;47:485–505.
12. González H, Pacheco R. T-cell-mediated regulation 
of neuroinflammation involved in neurodegenerative 
diseases. J Neuroinflammation. 2014;11:201. Review.
13. Sugiura S, Lahav R, Han J, Kou SY, Banner LR, de 
Pablo F, Patterson PH. Leukaemia inhibitory factor 
is required for normal inflammatory responses to 
injury in the peripheral and central nervous systems 
359
Neuroprotective effect of rhLIF in mice with an experimental cuprizone model of multiple sclerosis: possible mechanisms
in vivo and is chemotactic for macrophages in vitro. 
Eur J Neurosci. 2000;12(2):457–66.
14. Gudi V, Gingele S, Skripuletz T, Stangel M. Glial 
response during cuprizone-induced de- and remy-
elination in the CNS: lessons learned. Front Cell 
Neurosci. 2014;8:73. 
15. Banner LR, Patterson PH, Allchorne A, Poole S, 
Woolf CJ. Leukemia inhibitory factor is an anti-
inflammatory and analgesic cytokine. J Neurosci. 
1998;18(14):5456–62.
16. Acs P, Selak MA, Komoly S, Kalman B. Distribution 
of oligodendrocyte loss and mitochondrial toxicity 
in the cuprizone-induced experimental demyelination 
model. J Neuroimmunol. 2013;262(1–2):128–31.
17. Labunets IF, Melnyk NO, Kuzminova IA, Buten-
ko GM. Pat N 94458 UA (G09B 23. 28 (2006.01)), 
«Modeling of the structural changes of the central 
nervous system neurons in demyelinating diseases» 
N u 2014 06622; publ. 11.10.2014, Bull. N 21.
18. Xuan Y, Yan G, Wu R, Huang Q, Li X, Xu H. The 
cuprizone-induced changes in (1)H-MRS metabo-
lites and oxidative parameters in C57BL/6 mouse 
brain: Effects of quetiapine. Neurochem Int. 
2015;90:185–92.
19. Rymar SE, Novikova SN, Irodov DM, Bazalii AV, 
Sukhorada EM, Kordum VA. Leukemia inhibitory 
factor: perspectives for use in medicine and develop-
ment of its producer. J NAMS Ukraine. 2010; 
16:199–212.
20. Marriott MP, Emery B, Cate HS, Binder MD, Kem-
per D, Wu Q, Kolbe S, Gordon IR, Wang H, Egan G, 
Murray S, Butzkueven H, Kilpatrick TJ. Leukemia 
inhibitory factor signaling modulates both central 
nervous system demyelination and myelin repair. 
Glia. 2008;56(6):686–98.
21. Labunets IF, Melnyk NO, Rymar SYu. Pat N 104976 
UA (G09B 23. 28 (2006.01)) «Modeling of regen-
eration of damaged brain neurons during neurode-
generative diseases”, N u 2015 09252; publ. 
02.25.2016, Bull N 4.
22. Labunets IF, Melnyk NO, Kuzminova IA, Pod’iachen-
ko EV, Butenko GM. Effect of neurotoxin “cuprizone” 
on behavioral reactions and morphofunctional chang-
es of cerebral and spinal cord neurons in mice. J 
NAMS Ukraine. 2014; 20(4):402–8.
23. Amikishieva AV. Behavioral phenotyping: modern 
methods and equipment. Vestnik VOGiS. 2009; 
13:529–42.
24. Mihara M, Uchiyama M. Determination of malo-
naldehyde precursor in tissues by thiobarbituric acid 
test. Anal Biochem. 1978;86(1):271–8.
25. Muradian KhK, Utko NA, Mozzhukhina TG, 
Pishel’ IN, Litoshenko AIa, Bezrukov VV, 
Fraĭfel’d VE. [Correlative links between superoxide 
dismutase, catalase and glutathione peroxidase ac-
tivities in mouse liver]. Ukr Biokhim Zh. (1999). 
2003;75(1):33–7. Russian.
26. Guillemin GJ, Brew BJ. Microglia, macrophages, 
perivascular macrophages, and pericytes: a review 
of function and identification. J Leukoc Biol. 
2004;75(3):388–97.
27. Jordan FL, Wynder HJ, Booth PL, Thomas WE. 
Method for the identification of brain macrophages/
phagocytic cells in vitro. J Neurosci Res. 
1990;26(1):74–82.
28. Preclinical studies of drugs (guidelines). Ed. OV 
Stephanov. Kiev: Avicenna, 2001. 528 p.
29. Lakin GF. Biometrics. Moscow: High School Publ. 
1990, 350 p.
30. Labunets IF, Melnyk NO, Rodnichenko AE, Ry-
mar SE, Utko NA. Cuprizone-Induced Disorders of 
Central Nervous System Neurons, Behavioral Reac-
tions, Brain Activity of Macrophages and Antioxi-
dant Enzymes in the Mice of Different Ages: Role 
of Leukemia Inhibitory Factor in their Improvement. 
J Aging Geriatr Med. 2017; 1:2. 8 p. 
31. Ganong V,F. Human physiology. Lviv: BaK, 2002. 
784 p.
32. Lynch MA. Age-related neuroinflammatory chan ges 
negatively impact on neuronal function. Frontiers 
in Aging Neuroscience. 2010; 1, Article 6. — 8 p. 
Doi 10.3389. neuro.24.006.2009.
33. Kang Z, Liu L, Spangler R, Spear Ch, Wang Ch, 
Gulen MF, Veenstra M, Ouyang W, Ransohoff RM, 
Li X. IL-17-induced Act1-mediated signalling is 
critical for cuprizone-induced demyelination. J Neu-
rosci. 2012; 32(4):8284–92.
34. Vanderlocht J, Hellings N, Hendriks JJ, et al. Leu-
kemia inhibitory factor is produced by myelin-re-
active T cells from multiple sclerosis patients and 
360
I. F. Labunets, A. E. Rodnichenko, N. O. Melnyk et al.
protects against tumor necrosis factor-alpha-induced 
oligodendrocyte apoptosis. J Neurosci Res. 
2006;83(5):763–74.
35. Cao W, Yang Y, Wang Z, Liu A, et al. Leukemia 
inhibitory factor inhibits T helper 17 cell differen-
tiation and confers treatment effects of neural pro-
genitor cell therapy in autoimmune disease. Immu-
nity. 2011;35(2):273–84.
36. Chollangi S, Wang J, Martin A, Quinn J, Ash JD. 
Preconditioning-induced protection from oxidative 
injury is mediated by leukemia inhibitory factor 
receptor (LIFR) and its ligands in the retina. Neu-
robiol Dis. 2009;34(3):535–44.
Нейропротекторний ефект рекомбінантного 
лейкемія-інгібіторного фактору людини у мишей 
з експериментальною купризоновою моделлю 
розсіяного склерозу: можливі механізми
І. Ф. Лабунець, А. Є. Родніченко, Н. О. Мельник, 
С. Ю. Римар, Н. О. Утко, Г. О. Гаврилюк-Скиба, 
Г. М. Бутенкo
Мета. Дослідити вплив рекомбінантного лейкемія ін-
гібіторного фактору людини (rhLIF) на структурні та 
функціональні зміни ЦНС в експериментальній моде-
лі розсіяного склерозу, індукованого у мишей купризо-
ном; оцінити участь макрофагів, Т-лімфоцитів та анти-
оксидантних ферментів головного мозку в реалізації 
його проявів. Методи. Молоді миші лінії 129/Sv отри-
мували нейротоксин купризон із їжею щодня протягом 
3-х тижнів, rhLIF — з 8-ї доби прийому купризону 
щодня у дозі 50 мкг/кг. Методи: гістологічний, про-
точної цитометрії, спектрофотометричний і функціо-
нальний. Результати. Під впливом купризону в голов-
ному та спинному мозку мишей збільшується кількість 
нейронів з деструктивними змінами; в головному моз-
ку зростає кількість макрофагів, СD3+-клітин і вміст 
малонового діальдегіду; знижується активність супер-
оксидддисмутази, глютатіонпероксидази у головному 
мозку та змінюється поведінка тварин. Ін’єкції rhLIF 
частково або повністю відновлюють показники, зміне-
ні купризоном. Ефект цитокіна зберігається через 2 міс 
після завершення експерименту. Висновки. Нейро-
протекторний ефект rhLIF пов’язаний з пригніченням 
індукованих купризоном змін в активності антиокси-
дантних ферментів, кількості Т-клітин і макрофагів у 
головному мозку
К л юч ов і  с л ов а: купризон, LIF, нейрон, Т-лімфо-
цити, макрофаги, антиоксидантні ферменти.
Нейропротекторный эффект рекомбинантного 
лейкемия-ингибирующего фактора человека 
у мышей с экспериментальной купризоновой 
моделью рассеянного склероза: возможные 
механизмы
И. Ф. Лабунец, А. Е. Родниченко, Н. А. Мельник, 
С. Е. Рымарь, Н. А. Утко, Г. А. Гаврилюк-Скиба, 
Г. М. Бутенкo
Цель. Исследовать влияние рекомбинантного лейке-
мия- ингибирующего фактора человека (rhLIF) на 
структурные и функциональные изменения ЦНС в 
экспериментальной модели рассеянного склероза, 
индуцированного у мышей купризоном; оценить уча-
стие макрофагов, Т-лимфоцитов и антиоксидантных 
ферментов головного мозга в реализации его проявле-
ний. Методы. Молодые мыши линии 129/Sv получали 
нейротоксин купризон с пищей ежедневно в течение 
3-х недель, rhLIF — с 8-го дня приема купризона еже-
дневно в дозе 50 мкг/кг. Методы: гистологический, 
проточной цитометрии, спектрофотометрический и 
функциональный. Результаты. Прием купризона вы-
зывает увеличение числа нейронов с деструктивными 
изменениями в головном и спинном мозге, количества 
макрофагов, СD3+-клеток и содержания малонового 
диальдегида в головном мозге; наблюдается снижение 
активности супероксиддисмутазы, глютатионперокси-
дазы в головном мозге и изменение поведения живот-
ных. Инъекции rhLIF частично или полностью восста-
навливают измененные купризоном показатели. 
Эффект цитокина сохраняется через 2 мес после за-
вершения эксперимента. Выводы. Нейропротекторный 
эффект rhLIF связан с подавлением индуцированных 
купризоном изменений в активности антиоксидантных 
ферментов, количестве Т-клеток и макрофагов в го-
ловном мозге. 
К л юч е в ы е  с л ов а: купризон, LIF, нейрон, Т-лим-
фо циты, макрофаги, антиоксидантные ферменты.
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